Plaque psoriasis patients are more likely to receive immunosuppressive treatment intermittently and for longer periods of time, which would cause microbiome dysbiosis, leading to increased C. albicans colonization and an increased presence of specific IgA in plasma. Here, CD79A is linked to psoriasis.